Switching to Sirolimus in Renal Transplant Recipients With Hepatitis C Virus: A Safe Option

Hepatitis C Virus Infection

2001 • 2,979 citations

European Best Practice Guidelines for Renal Transplantation (Part 2).

2002 • 370 citations

Hepatitis C Virus Antibody Status and Survival After Renal Transplantation: Meta-Analysis of Observational Studies

2005 • 261 citations

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

1999 • 211 citations

Hepatitis C Virus Infection and de Novo Glomerular Lesions in Renal Allografts

2001 • 191 citations

Pretransplant Interferon Prevents Hepatitis C Virus-Associated Glomerulonephritis in Renal Allografts by HCV-RNA Clearance

2003 • 122 citations

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival.

2001 • 115 citations

Hepatitis C Virus Seropositivity at the Time of Renal Transplantation in the United States: Associated Factors and Patient Survival

2001 • 105 citations

Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms

2005 • 79 citations

OUTCOME OF CADAVERIC RENAL TRANSPLANT PATIENTS TREATED FOR 10 YEARS WITH CYCLOSPORINE

2001 • 56 citations

Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis

2005 • 51 citations

Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions

2003 • 20 citations